04:21 PM EDT, 09/08/2025 (MT Newswires) -- Dianthus Therapeutics ( DNTH ) said late Monday it has launched an underwritten public offering of $150 million of its shares.

The company said it will grant its underwriters, including Jefferies and TD Cowen, a 30-day option to buy up to an additional $22.5 million of its shares. Investors can also buy pre-funded warrants in lieu of stock.

Dianthus said it plans to use the net proceeds to help further its drug development, for working capital and general corporate purposes.